Proteinuria – pipeline review, h1 2012


Published on || Proteinuria – Pipeline Review, H1 2012 || Market Research latest report

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Proteinuria – pipeline review, h1 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Proteinuria – Pipeline Review, H1 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, Proteinuria - Pipeline Review, H1 2012, provides anoverview of the Proteinuria therapeutic pipeline. This report provides informationon the therapeutic development for Proteinuria, complete with latest updates, andspecial features on late-stage and discontinued projects. It also reviews key playersinvolved in the therapeutic development for Proteinuria. Proteinuria - PipelineReview, H1 2012 is built using data and information sourced from Global MarketsDirect’s proprietary databases, Company/University websites, SEC filings, investorpresentations and featured press releases from company/university sites andindustry-specific third party sources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Proteinuria.- A review of the Proteinuria products under development by companies anduniversities/research institutes based on information derived from company andindustry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.- A feature on pipeline projects on the basis of monotherapy and combinedtherapeutics.
  2. 2. Table of contents:List of Tables 4List of Figures 4Introduction 5Global Markets Direct Report Coverage 5Proteinuria Overview 6Therapeutics Development 7An Overview of Pipeline Products for Proteinuria 7Proteinuria Therapeutics under Development by Companies 9Proteinuria Therapeutics under Investigation by Universities/Institutes 10Late Stage Products 12Comparative Analysis 12Mid Clinical Stage Products 13Comparative Analysis 13Early Clinical Stage Products 14Comparative Analysis 14Proteinuria Therapeutics – Products under Development by Companies 15Proteinuria Therapeutics – Products under Investigation by Universities/Institutes16Companies Involved in Proteinuria Therapeutics Development 17Evolva SA 17Symphony Evolution, Inc. 18InVasc Therapeutics, Inc. 19Proteinuria – Therapeutics Assessment 20Assessment by Monotherapy Products 20Assessment by Combination Products 21Assessment by Route of Administration 22Assessment by Molecule Type 24Drug Profiles 26EV-077 - Drug Profile 26Product Description 26Mechanism of Action 26R&D Progress 26Mycophenolate Mofetil + Prednisolone - Drug Profile 28
  3. 3. Product Description 28Mechanism of Action 28R&D Progress 28Pentoxifylline + Enalapril + Losartan - Drug Profile 30List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H1 2012 Review, H12012&PubId=&pagenum=1Refractory Angina – Pipeline Review, H1 2012Post-Myocardial Infarction – Pipeline Review, H1 2012Proteinuria – Pipeline Review, H1 2012Ocular Pain – Pipeline Review, H1 2012Pediculosis (Head Lice Infestation) – Pipeline Review, H1 2012Allergic Rhino-Conjunctivitis – Pipeline Review, H1 2012Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H1 2012
  4. 4. Thyroid Gland Disorders – Pipeline Review, H1 2012Tinea Corporis – Pipeline Review, H1 2012Pulmonary Fibrosis – Pipeline Review, H1 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: